MedTrace Logo

Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin

NCT00287807 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-09-26

No results posted yet for this study

Summary

Self-monitoring of blood glucose (SMBG) is one of the important instruments in diabetes management. Most patients with type 1 diabetes and patients with type 2 using insulin, frequently measure their blood glucose in case of possible hypoglycemia, but also to evaluate the insulin treatment and get information about how to change the insulin regimen, if necessary. Without SMBG it is almost impossible to achieve this goal.

The purpose of this study is to determine if self-monitoring in patients with type 2 diabetes not using insulin results in better glycemic control.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Self-monitoring of blood glucose (SMBG)

2 times a week (one in weekend and one during week) self measurement of blood glucose: fasting and three times post prandial

Sponsors & Collaborators

  • Langerhans Foundation, the Netherlands

    collaborator OTHER

  • Medical Research Foundation, The Netherlands

    lead OTHER

Principal Investigators

  • Henk J Bilo, MD; PhD · Isala Clinics, medical research foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287807 on ClinicalTrials.gov